Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swedish (OMX) Healthcare Services Industry Analysis

UpdatedJan 07, 2026
DataAggregated Company Financials
Companies9
  • 7D-3.2%
  • 3M-6.6%
  • 1Y23.2%
  • YTD-0.4%

Over the last 7 days, the Healthcare Services industry has dropped 3.2%, driven by a pullback from Medicover of 5.7%. In the past year, the industry has gained 23%. Looking forward, earnings are forecast to grow by 23% annually.

Industry Valuation and Performance

Has the Swedish Healthcare Services Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 07 Jan 2026SEK 91.2bSEK 89.0bSEK 2.9b18.1x31.5x1x
Fri, 05 Dec 2025SEK 62.1bSEK 73.1bSEK 2.4b17.1x26.1x0.9x
Sun, 02 Nov 2025SEK 66.3bSEK 71.8bSEK 2.1b17.4x31.9x0.9x
Tue, 30 Sep 2025SEK 64.7bSEK 72.4bSEK 2.0b17.8x33.1x0.9x
Thu, 28 Aug 2025SEK 66.6bSEK 72.4bSEK 2.0b17.5x34x0.9x
Sat, 26 Jul 2025SEK 68.1bSEK 72.1bSEK 1.9b16.7x35.8x0.9x
Mon, 23 Jun 2025SEK 57.9bSEK 71.3bSEK 1.7b15.6x34x0.8x
Wed, 21 May 2025SEK 60.2bSEK 70.7bSEK 1.7b16.6x35.5x0.9x
Fri, 18 Apr 2025SEK 55.7bSEK 69.4bSEK 1.4b17.9x39.6x0.8x
Sun, 16 Mar 2025SEK 53.1bSEK 69.5bSEK 1.4b18.8x37.8x0.8x
Tue, 11 Feb 2025SEK 54.2bSEK 84.0bSEK 1.8b18.7x30.2x0.6x
Thu, 09 Jan 2025SEK 48.1bSEK 68.6bSEK 1.4b17.4x35.1x0.7x
Sat, 07 Dec 2024SEK 48.3bSEK 68.7bSEK 1.4b17.7x35.2x0.7x
Mon, 04 Nov 2024SEK 46.8bSEK 68.7bSEK 1.2b17.1x39.1x0.7x
Wed, 02 Oct 2024SEK 47.2bSEK 66.6bSEK 1.2b18.8x38x0.7x
Fri, 30 Aug 2024SEK 46.7bSEK 66.5bSEK 1.2b19x37.6x0.7x
Sun, 28 Jul 2024SEK 46.8bSEK 67.1bSEK 1.2b14.9x38.9x0.7x
Tue, 25 Jun 2024SEK 46.8bSEK 64.6bSEK 1.3b13.6x36.1x0.7x
Thu, 23 May 2024SEK 44.9bSEK 65.3bSEK 1.3b14.1x34.4x0.7x
Sat, 20 Apr 2024SEK 36.5bSEK 64.0bSEK 1.2b12.4x29.7x0.6x
Mon, 18 Mar 2024SEK 35.2bSEK 63.4bSEK 1.2b12.1x28.8x0.6x
Wed, 14 Feb 2024SEK 36.8bSEK 63.6bSEK 1.2b11.3x29.6x0.6x
Fri, 12 Jan 2024SEK 37.7bSEK 61.9bSEK 940.2m14.1x40.1x0.6x
Sun, 10 Dec 2023SEK 34.4bSEK 61.9bSEK 956.6m12.4x36x0.6x
Tue, 07 Nov 2023SEK 33.1bSEK 62.6bSEK 1.1b12.1x31.1x0.5x
Thu, 05 Oct 2023SEK 32.6bSEK 60.6bSEK 903.9m10.2x36.1x0.5x
Sat, 02 Sep 2023SEK 35.1bSEK 61.0bSEK 905.6m10.4x38.7x0.6x
Mon, 31 Jul 2023SEK 35.5bSEK 60.3bSEK 944.4m8.5x37.6x0.6x
Wed, 28 Jun 2023SEK 34.6bSEK 58.7bSEK 768.7m10.7x45.1x0.6x
Fri, 26 May 2023SEK 36.9bSEK 58.5bSEK 768.4m11.5x48x0.6x
Sun, 23 Apr 2023SEK 39.0bSEK 56.7bSEK 803.7m12x48.6x0.7x
Tue, 21 Mar 2023SEK 35.8bSEK 56.4bSEK 797.3m13.5x44.9x0.6x
Thu, 16 Feb 2023SEK 37.9bSEK 56.0bSEK 1.1b13.1x35.2x0.7x
Sat, 14 Jan 2023SEK 35.9bSEK 55.1bSEK 1.0b12.4x34.7x0.7x
Price to Earnings Ratio

34.7x


Total Market Cap: SEK 35.9bTotal Earnings: SEK 1.0bTotal Revenue: SEK 55.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Healthcare Services Industry Price to Earnings3Y Average 37x202420252026
Current Industry PE
  • Investors are pessimistic on the Swedish Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 31.5x which is lower than its 3-year average PE of 37.0x.
  • The 3-year average PS ratio of 0.71x is lower than the industry's current PS ratio of 1.0x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 41% per year over the last three years.
  • Revenues for these companies have grown 17% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market0.026%
Healthcare-1.62%
Healthcare Services-3.17%
Healthcare Facilities-0.77%
Healthcare Distributors-2.67%
Healthcare Services-5.53%
Industry PE
  • Investors are most optimistic about the Healthcare Distributors industry which is trading above its 3-year average PE ratio of 49.6x.
    • Analysts expect its future annual earnings growth (27.2%) to be largely in line with prior year's earnings growth.
  • Investors are most pessimistic about the Healthcare Facilities industry, which is trading close to its 3-year average of 15.2x.
Forecasted Growth
  • Analysts are most optimistic on the Healthcare Distributors industry, expecting annual earnings growth of 27% over the next 5 years.
  • This is roughly in line with its past earnings growth rate.
  • In contrast, the Healthcare Facilities industry is expected to see its earnings grow by 14% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
HUM HumanaSEK 51.101.4%
+SEK 34.5m		39.2%PE10.5x
DEDI DedicareSEK 44.254.1%
+SEK 16.7m		-29.1%PE10.6x
ATT AttendoSEK 82.000.1%
+SEK 14.6m		63.3%PE18.1x
HEGR Hedera GroupSEK 0.6617.0%
+SEK 3.2m		-81.8%PS0.04x

Latest News

ASKER
SEK 82.14
Asker Healthcare Group
7D
-2.7%
1Y
n/a

Investors Interested In Asker Healthcare Group AB's (STO:ASKER) Earnings

Jan 04
Investors Interested In Asker Healthcare Group AB's (STO:ASKER) Earnings
ATT
SEK 82.00
Attendo
7D
0.1%
1Y
63.3%
HEGR
SEK 0.66
Hedera Group
7D
17.0%
1Y
-81.8%
MCOV B
SEK 208.00
Medicover
7D
-5.7%
1Y
10.9%

MCOV B: MRD Study Progress Will Support Steady Long Term Outlook

Analysts have raised their price target on Medicover to SEK 230.73 per share, reflecting modestly stronger expectations for long term revenue growth and profit margins despite an essentially unchanged valuation framework. What's in the News Medicover reported additional data from the ongoing DART phase II clinical study at Oslo University Hospital, using Medicover Genetics' hybrid capture based, tumour agnostic MRD assay in unresectable stage III NSCLC patients (Key Developments).
EQL
SEK 56.30
EQL Pharma
7D
-2.6%
1Y
-33.1%
AMBEA
SEK 138.30
Ambea
7D
-2.1%
1Y
51.1%

Why Ambea AB (publ) (STO:AMBEA) Could Be Worth Watching

Dec 15
Why Ambea AB (publ) (STO:AMBEA) Could Be Worth Watching
HUM
SEK 51.10
Humana
7D
1.4%
1Y
39.2%

HUM: Modest Margin Gains Will Likely Support Stronger Future Share Performance

Analysts have modestly increased their price target on Humana by refining key valuation inputs, reflecting slightly higher confidence in the company’s long term earnings power and stability, while maintaining a fair value estimate of approximately 60.00 dollars per share. Valuation Changes Fair Value: Unchanged at approximately 60.00 dollars per share, indicating stable overall valuation despite model refinements.
NGS
SEK 2.57
NGS Group
7D
-0.4%
1Y
-19.4%

NGS Group (NGM:NGS) Has Some Difficulty Using Its Capital Effectively

Dec 07
NGS Group (NGM:NGS) Has Some Difficulty Using Its Capital Effectively
DEDI
SEK 44.25
Dedicare
7D
4.1%
1Y
-29.1%